Clearmind Medicine Expands Clinical Trial for Alcohol Use Disorder with New Israeli Site Clearmind Medicine Inc., (Nasdaq: CMND) a biotech company focused on psychedelic-based therapies, has announced the expansion of its Phase I/IIa clinical trial

#CMND is expanding its groundbreaking clinical trial for Alcohol Use Disorder (AUD) with the addition of Tel Aviv Sourasky Medical Center as a new research site.
#ClearmindCMND #AlcoholUseDisorder
prismmarketview.com/clearmind-me...